annual CAPEX:
$146.96M+$59.61M(+68.25%)Summary
- As of today (August 20, 2025), SRPT annual capital expenditures is $146.96 million, with the most recent change of +$59.61 million (+68.25%) on December 31, 2024.
- During the last 3 years, SRPT annual CAPEX has risen by +$106.16 million (+260.20%).
- SRPT annual CAPEX is now at all-time high.
Performance
SRPT CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$31.98M-$13.90M(-30.30%)Summary
- As of today (August 20, 2025), SRPT quarterly capital expenditures is $31.98 million, with the most recent change of -$13.90 million (-30.30%) on June 30, 2025.
- Over the past year, SRPT quarterly CAPEX has increased by +$2.82 million (+9.66%).
- SRPT quarterly CAPEX is now -30.30% below its all-time high of $45.89 million, reached on March 31, 2025.
Performance
SRPT quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$153.22M+$2.82M(+1.87%)Summary
- As of today (August 20, 2025), SRPT TTM capital expenditures is $153.22 million, with the most recent change of +$2.82 million (+1.87%) on June 30, 2025.
- Over the past year, SRPT TTM CAPEX has increased by +$21.66 million (+16.46%).
- SRPT TTM CAPEX is now at all-time high.
Performance
SRPT TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
SRPT CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +68.3% | +9.7% | +16.5% |
| 3 y3 years | +260.2% | +252.3% | +487.6% |
| 5 y5 years | +146.4% | +66.8% | +170.7% |
SRPT CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +355.7% | -30.3% | +301.6% | at high | +511.3% |
| 5 y | 5-year | at high | +355.7% | -30.3% | +1349.9% | at high | +569.3% |
| alltime | all time | at high | >+9999.0% | -30.3% | >+9999.0% | at high | >+9999.0% |
SRPT CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $31.98M(-30.3%) | $153.22M(+1.9%) |
| Mar 2025 | - | $45.89M(+20.5%) | $150.40M(+2.3%) |
| Dec 2024 | $146.96M(+68.2%) | $38.08M(+2.2%) | $146.96M(+14.9%) |
| Sep 2024 | - | $37.26M(+27.8%) | $127.91M(-2.8%) |
| Jun 2024 | - | $29.17M(-31.3%) | $131.56M(+9.4%) |
| Mar 2024 | - | $42.44M(+122.9%) | $120.30M(+37.7%) |
| Dec 2023 | $87.34M(+170.8%) | $19.04M(-53.5%) | $87.34M(+14.5%) |
| Sep 2023 | - | $40.91M(+128.4%) | $76.27M(+75.0%) |
| Jun 2023 | - | $17.91M(+88.8%) | $43.59M(+25.4%) |
| Mar 2023 | - | $9.48M(+19.1%) | $34.76M(+12.8%) |
| Dec 2022 | $32.25M(-21.0%) | $7.96M(-3.2%) | $30.82M(+23.0%) |
| Sep 2022 | - | $8.23M(-9.3%) | $25.07M(-3.9%) |
| Jun 2022 | - | $9.08M(+63.5%) | $26.08M(+13.9%) |
| Mar 2022 | - | $5.55M(+151.6%) | $22.89M(-40.5%) |
| Dec 2021 | $40.80M(-50.4%) | $2.21M(-76.1%) | $38.49M(-43.7%) |
| Sep 2021 | - | $9.24M(+56.8%) | $68.39M(-19.0%) |
| Jun 2021 | - | $5.89M(-72.1%) | $84.46M(-13.6%) |
| Mar 2021 | - | $21.15M(-34.1%) | $97.73M(+14.0%) |
| Dec 2020 | $82.20M(+37.9%) | $32.11M(+26.9%) | $85.70M(+19.2%) |
| Sep 2020 | - | $25.30M(+32.0%) | $71.88M(+27.0%) |
| Jun 2020 | - | $19.17M(+110.2%) | $56.60M(+3.5%) |
| Mar 2020 | - | $9.12M(-50.1%) | $54.72M(-12.8%) |
| Dec 2019 | $59.63M(-2.5%) | $18.29M(+82.5%) | $62.71M(-3.8%) |
| Sep 2019 | - | $10.02M(-42.0%) | $65.18M(-14.6%) |
| Jun 2019 | - | $17.28M(+1.0%) | $76.33M(+11.2%) |
| Mar 2019 | - | $17.12M(-17.5%) | $68.62M(+6.7%) |
| Dec 2018 | $61.16M(+188.3%) | $20.76M(-1.9%) | $64.34M(+33.7%) |
| Sep 2018 | - | $21.17M(+121.0%) | $48.11M(+38.7%) |
| Jun 2018 | - | $9.58M(-25.4%) | $34.70M(+22.4%) |
| Mar 2018 | - | $12.84M(+183.9%) | $28.34M(+33.6%) |
| Dec 2017 | $21.21M(+209.0%) | $4.52M(-41.7%) | $21.21M(+5.9%) |
| Sep 2017 | - | $7.75M(+140.3%) | $20.04M(+49.0%) |
| Jun 2017 | - | $3.23M(-43.5%) | $13.45M(+22.3%) |
| Mar 2017 | - | $5.71M(+70.7%) | $11.00M(+60.2%) |
| Dec 2016 | $6.87M(+42.1%) | $3.35M(+187.2%) | $6.87M(+35.8%) |
| Sep 2016 | - | $1.17M(+49.9%) | $5.05M(-6.0%) |
| Jun 2016 | - | $777.00K(-50.8%) | $5.38M(-2.0%) |
| Mar 2016 | - | $1.58M(+2.8%) | $5.49M(+13.6%) |
| Dec 2015 | $4.83M(-82.0%) | $1.53M(+3.1%) | $4.83M(-28.5%) |
| Sep 2015 | - | $1.49M(+68.1%) | $6.76M(-62.8%) |
| Jun 2015 | - | $886.00K(-4.0%) | $18.16M(-17.9%) |
| Mar 2015 | - | $923.00K(-73.3%) | $22.13M(-17.5%) |
| Dec 2014 | $26.82M(+610.6%) | $3.46M(-73.2%) | $26.82M(+11.3%) |
| Sep 2014 | - | $12.90M(+166.0%) | $24.10M(+87.1%) |
| Jun 2014 | - | $4.85M(-13.7%) | $12.88M(+44.3%) |
| Mar 2014 | - | $5.62M(+667.8%) | $8.93M(+136.4%) |
| Dec 2013 | $3.77M(+229.7%) | $732.00K(-56.4%) | $3.77M(+8.9%) |
| Sep 2013 | - | $1.68M(+87.2%) | $3.47M(+85.3%) |
| Jun 2013 | - | $896.00K(+90.6%) | $1.87M(+38.2%) |
| Mar 2013 | - | $470.00K(+11.1%) | $1.35M(+18.2%) |
| Dec 2012 | $1.15M(-50.3%) | $423.00K(+422.2%) | $1.15M(-24.0%) |
| Sep 2012 | - | $81.00K(-78.6%) | $1.51M(-13.7%) |
| Jun 2012 | - | $379.00K(+44.7%) | $1.75M(-21.8%) |
| Mar 2012 | - | $262.00K(-66.6%) | $2.23M(-3.2%) |
| Dec 2011 | $2.31M | $784.00K(+145.0%) | $2.31M(+13.8%) |
| Sep 2011 | - | $320.00K(-63.0%) | $2.03M(-7.6%) |
| Jun 2011 | - | $865.00K(+157.4%) | $2.19M(+22.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2011 | - | $336.00K(-33.5%) | $1.79M(-8.6%) |
| Dec 2010 | $1.95M(-2.0%) | $505.00K(+3.7%) | $1.95M(-19.1%) |
| Sep 2010 | - | $487.00K(+6.3%) | $2.42M(+6.9%) |
| Jun 2010 | - | $458.00K(-9.1%) | $2.26M(+2.6%) |
| Mar 2010 | - | $504.00K(-47.9%) | $2.20M(+10.4%) |
| Dec 2009 | $1.99M(+63.8%) | $967.00K(+193.0%) | $1.99M(+36.4%) |
| Sep 2009 | - | $330.00K(-17.7%) | $1.46M(+11.4%) |
| Jun 2009 | - | $401.00K(+35.5%) | $1.31M(+11.7%) |
| Mar 2009 | - | $296.00K(-31.9%) | $1.17M(-3.5%) |
| Dec 2008 | $1.22M(-42.8%) | $434.90K(+141.7%) | $1.22M(+10.1%) |
| Sep 2008 | - | $179.90K(-31.8%) | $1.11M(-13.7%) |
| Jun 2008 | - | $263.80K(-22.2%) | $1.28M(-5.1%) |
| Mar 2008 | - | $339.00K(+4.8%) | $1.35M(-8.5%) |
| Dec 2007 | $2.13M(+46.3%) | $323.60K(-8.8%) | $1.48M(+24.6%) |
| Sep 2007 | - | $354.80K(+6.6%) | $1.18M(+7.5%) |
| Jun 2007 | - | $332.90K(-28.3%) | $1.10M(+6.2%) |
| Mar 2007 | - | $464.00K(+1332.1%) | $1.04M(+35.1%) |
| Dec 2006 | $1.45M(-1.0%) | $32.40K(-88.1%) | $767.20K(-15.8%) |
| Sep 2006 | - | $272.10K(+1.5%) | $911.40K(-5.1%) |
| Jun 2006 | - | $268.20K(+37.9%) | $960.30K(-3.8%) |
| Mar 2006 | - | $194.50K(+10.1%) | $998.20K(-6.8%) |
| Dec 2005 | $1.47M(+37.1%) | $176.60K(-45.0%) | $1.07M(-6.7%) |
| Sep 2005 | - | $321.00K(+4.9%) | $1.15M(-10.3%) |
| Jun 2005 | - | $306.10K(+14.6%) | $1.28M(+7.8%) |
| Mar 2005 | - | $267.20K(+5.2%) | $1.19M(+11.0%) |
| Dec 2004 | $1.07M(-34.7%) | $254.10K(-43.9%) | $1.07M(-5.0%) |
| Sep 2004 | - | $453.00K(+111.8%) | $1.13M(+27.5%) |
| Jun 2004 | - | $213.90K(+43.3%) | $884.20K(-12.6%) |
| Mar 2004 | - | $149.30K(-52.0%) | $1.01M(-38.3%) |
| Dec 2003 | $1.64M(-41.0%) | $311.00K(+48.1%) | $1.64M(-23.9%) |
| Sep 2003 | - | $210.00K(-38.5%) | $2.16M(-17.7%) |
| Jun 2003 | - | $341.40K(-56.1%) | $2.62M(-3.2%) |
| Mar 2003 | - | $777.60K(-6.0%) | $2.71M(-2.6%) |
| Dec 2002 | $2.78M(-33.5%) | $827.00K(+22.9%) | $2.78M(-26.4%) |
| Sep 2002 | - | $673.00K(+56.9%) | $3.77M(-4.0%) |
| Jun 2002 | - | $428.90K(-49.5%) | $3.93M(-1.9%) |
| Mar 2002 | - | $849.10K(-53.4%) | $4.01M(-4.1%) |
| Dec 2001 | $4.18M(+413.7%) | $1.82M(+119.2%) | $4.18M(+58.4%) |
| Sep 2001 | - | $830.90K(+64.4%) | $2.64M(+24.7%) |
| Jun 2001 | - | $505.40K(-50.4%) | $2.11M(+19.0%) |
| Mar 2001 | - | $1.02M(+263.8%) | $1.78M(+118.4%) |
| Dec 2000 | $813.20K(+306.6%) | $280.30K(-9.0%) | $813.10K(+52.2%) |
| Sep 2000 | - | $308.00K(+83.1%) | $534.20K(+113.6%) |
| Jun 2000 | - | $168.20K(+197.2%) | $250.10K(+177.9%) |
| Mar 2000 | - | $56.60K(+3942.9%) | $90.00K(-33.4%) |
| Dec 1999 | $200.00K(-91.3%) | $1400.00(-94.1%) | $135.10K(-27.8%) |
| Sep 1999 | - | $23.90K(+195.1%) | $187.00K(-1.1%) |
| Jun 1999 | - | $8100.00(-92.0%) | $189.10K(-7.7%) |
| Mar 1999 | - | $101.70K(+90.8%) | $204.80K(+86.9%) |
| Dec 1998 | $2.30M(+666.7%) | $53.30K(+105.0%) | $109.60K(-57.2%) |
| Sep 1998 | - | $26.00K(+9.2%) | $256.30K(+11.3%) |
| Jun 1998 | - | $23.80K(+266.2%) | $230.30K(+11.5%) |
| Mar 1998 | - | $6500.00(-96.8%) | $206.50K(-31.2%) |
| Dec 1997 | $300.00K(+200.0%) | $200.00K(>+9900.0%) | $300.00K(+200.0%) |
| Sep 1997 | - | $0.00(0.0%) | $100.00K(0.0%) |
| Jun 1997 | - | $0.00(-100.0%) | $100.00K(0.0%) |
| Mar 1997 | - | $100.00K | $100.00K |
| Dec 1996 | $100.00K | - | - |
FAQ
- What is Sarepta Therapeutics, Inc. annual capital expenditures?
- What is the all time high annual CAPEX for Sarepta Therapeutics, Inc.?
- What is Sarepta Therapeutics, Inc. annual CAPEX year-on-year change?
- What is Sarepta Therapeutics, Inc. quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Sarepta Therapeutics, Inc.?
- What is Sarepta Therapeutics, Inc. quarterly CAPEX year-on-year change?
- What is Sarepta Therapeutics, Inc. TTM capital expenditures?
- What is the all time high TTM CAPEX for Sarepta Therapeutics, Inc.?
- What is Sarepta Therapeutics, Inc. TTM CAPEX year-on-year change?
What is Sarepta Therapeutics, Inc. annual capital expenditures?
The current annual CAPEX of SRPT is $146.96M
What is the all time high annual CAPEX for Sarepta Therapeutics, Inc.?
Sarepta Therapeutics, Inc. all-time high annual capital expenditures is $146.96M
What is Sarepta Therapeutics, Inc. annual CAPEX year-on-year change?
Over the past year, SRPT annual capital expenditures has changed by +$59.61M (+68.25%)
What is Sarepta Therapeutics, Inc. quarterly capital expenditures?
The current quarterly CAPEX of SRPT is $31.98M
What is the all time high quarterly CAPEX for Sarepta Therapeutics, Inc.?
Sarepta Therapeutics, Inc. all-time high quarterly capital expenditures is $45.89M
What is Sarepta Therapeutics, Inc. quarterly CAPEX year-on-year change?
Over the past year, SRPT quarterly capital expenditures has changed by +$2.82M (+9.66%)
What is Sarepta Therapeutics, Inc. TTM capital expenditures?
The current TTM CAPEX of SRPT is $153.22M
What is the all time high TTM CAPEX for Sarepta Therapeutics, Inc.?
Sarepta Therapeutics, Inc. all-time high TTM capital expenditures is $153.22M
What is Sarepta Therapeutics, Inc. TTM CAPEX year-on-year change?
Over the past year, SRPT TTM capital expenditures has changed by +$21.66M (+16.46%)